Newsletter of MEDICA | View in browser | Deutsch | Print

AI start-up improves evaluation in imaging

Dear Sir or Madam,

Munich-based AI start-up Floy brings advanced AI solutions to imaging which are already being used in many German radiology practices. Benedikt Schneider, CEO of Floy, emphasizes in the interview how their technology supports diagnostics by reliably detecting critical incidental findings. Particularly noteworthy is the development of screening software for osteoporosis, an often underdiagnosed widespread disease. Floy's AI technology opens up new perspectives in early detection and treatment, improves the quality of medical care and offers a remuneration model without financial risk for practices.

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

	Interview: AI start-up improves evaluation in imaging
	12th MEDICA MEDICINE + SPORTS CONFERENCE
	Newsletter Service

Image: Banner with the text: MEDICA Magazine – 365 days a year; Copyright: Messe Düsseldorf

Floy: AI start-up improves evaluation in imaging

Interview – DIGITAL HEALTH

Image: Hands of a female doctor who is looking at MRI pictures of the brain on a tablet; Copyright: YuriArcursPeopleimages

Floy from Munich brings AI in imaging into practical application and is already present in numerous German radiology practices. The start-up's software is designed to support radiologists in diagnostics and prevention by reliably detecting critical incidental findings.

Click here for the interview

	Floy: AI start-up improves evaluation in imaging
	Read all content from the Sphere of DIGITAL HEALTH in the MEDICA Magazine here

To top

UGRSKIN: artificial skin as a game-changer in burn treatment

News

DISPOSABLES

The University of Granada (UGR) has pioneered a solution for burn treatment with its artificial skin “UGRSKIN”. Developed by the Tissue Engineering Research Group, this advanced therapy medicinal product (ATMP) has improved the approach to treating severe burns, offering patients new hope and enhanced outcomes.

To top

12th MEDICA MEDICINE + SPORTS CONFERENCE

The MEDICA MEDICINE + SPORTS CONFERENCE (MMSC) is coming up for the 12th time as part of MEDICA from November 13th to November 14th, 2024. We are excited to bring together internationally renowned sports physicians, sports scientists, physiotherapists, sports technology experts, and visionaries for an interdisciplinary dialogue on innovative approaches to prevention, regeneration, and rehabilitation in top-class and health sports.

You are interested to take part at MMSC as a speaker? Submit your abstract for a presentation now!

Learn more about MMSC 2024:

	Call for Abstracts
	You can find all information about MMSC here

To top

HZDR team introduces novel pathogen detection approach

News

LAB & DIAGNOSTICS

Detecting diseases early or predicting their onset is crucial for healthcare. Dr. Larysa Baraban's team at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) develops miniaturized biosensor devices using nanomaterials.

To top

Determine stroke risk early with tear fluid, mitochondria and AI

News

LAB & DIAGNOSTICS

Over 100 million people globally suffer from strokes annually, with ischemic strokes being the most common. However, many strokes go undetected, leading to severe consequences like dementia or depression. Prof. Olga Golubnitschaja from the University Hospital Bonn (UKB) has spearheaded a comprehensive approach to assess stroke risk early, focusing on predictive medicine.

To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top

Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.